Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women: A 2-year double-blind placebo study

References

• Ajabor L. N., Tsai C. C., Vela P., Yen S. S. C. Effect of exogenous estrogen on carbohydrate metabolism in postmenopausal women. Am J Obstet Gynecol 1972; 113: 383
   Google Scholar
• Albanese A. A., Edelson A. H., Woodhull M. L., Lorenze E. J., Wein E. H., Orto L. A. Effect of calcium supplement on serum cholesterol, calcium, phosphorus and bone density of “normal, healthy” elderly females. Nutr Rep Int 1973; 8: 119
   Google Scholar
• Amery A., Berthaux P., Bulpitt C., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F., Hellemans J., Lund-Johansen P., Mutsers A., Tuomilehto J. Glucose intolerance during diuretic therapy. Results of trial by the European working party on hypertension in the elderly. Lancet 1978; i: 681
   Google Scholar
• Barrett-Connor E., Brown W. V., Turner J., Austin M., Criqui M. H. Heart disease risk factors and hormone use in postmenopausal women. JAMA 1979; 241: 2167
   PubMed Web of Science ®Google Scholar
• Benjamin F., Casper D. J. Alterations in carbohydrate metabolism induced by progesterone in cases of endometrial carcinoma and hyperplasia. Am J Obstet Gynecol 1966; 94: 991
   Google Scholar
• Bierenbaum M. L., Fleischman A. I., Raichelson R. I. Long term human studies on the lipid effects of oral calcium. Lipids 1972; 7: 202
   Google Scholar
• Böttiger L. E., Westerholm B. Thrombocytopenia. II. Druginduced thrombocytopenia. Acta Med Scand 1972; 191: 541
   Google Scholar
• Carlson L. A., Olsson A. G., Orö L., Rössner S. Effects of oral calcium upon serum cholesterol and triglycerides in patients with hyperlipidemia. Atherosclerosis 1971; 14: 391
   Google Scholar
• Christiansen C., Christensen M. S., McNair P., Hagen C., Stocklund K.-E., Transbøl I. Prevention of early postmenopausal bone loss. Controlled 2-year study in 315 normal females. Eur J Clin Invest 1980; 10: 273
   PubMed Web of Science ®Google Scholar
• Crane M. G., Harris J. J., Winsor W., III. Hypertension, oral contraceptive agents, and conjugated estrogens. Ann Intern Med 1971; 74: 13
   PubMed Web of Science ®Google Scholar
• Epstein F. H. The epidemiology of coronary heart disease. A review. J Chron Dis 1965; 18: 735
   PubMedGoogle Scholar
• Epstein F. H. Some uses of prospective observations in the Tecumseh community health study. Proc Roy Soc Med 1967; 60: 56
   Google Scholar
• Gambrell R. D., Jr. The prevention of endometrial carcinoma in postmenopausal women with progestogen. Maturitas 1978; 1: 107
   PubMed Web of Science ®Google Scholar
• Goldman J. A., Ovadia J. L. The effect of estrogen on intravenous glucose tolerance in women. Am J Obstet Gynecol 1969; 103: 172
   Google Scholar
• Grimm R. H., Leon A. S., Hunninghake D., Blackburn H. Diuretic effects on plasma lipids and lipoproteins. Clin Res 1978; 26: 290A
   Google Scholar
• Hammond C. B., Jelovsek F. R., Lee K. L., Creasman W. T., Parker R. T. Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol 1979; 133: 525
   PubMed Web of Science ®Google Scholar
• Hammond C. B., Jelovsek F. R., Lee K. L., Creasman W. T., Parker R. T. Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol 1979; 133: 537
   PubMed Web of Science ®Google Scholar
• Johnson B., Bye C., LaBrooy J., Munro-Faure D., Slack J. The relation of antihypertensive treatment to plasma lipids and other vascular risk factors in hypertensives. Clin Sci Mol Med 1974; 47: 9P
   Google Scholar
• Johnson B. F., Munro-Faure A. D., Slack J. Diuretic-induced hypertriglyceridaemia. Lancet 1976; i: 1019
   Google Scholar
• Kannel W. B., Castelli W. P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 1979; 90: 85
   PubMed Web of Science ®Google Scholar
• Kannel W. B., Gordon T., McGee D. Diuretics and serum cholesterol. Lancet 1977; i: 1362
   Google Scholar
• Kannel W. B., Schwartz M. J., McNamara P. M. Blood pressure and risk of coronary heart disease: The Framingham study. Dis Chest 1969; 56: 43
   PubMedGoogle Scholar
• Kirkendall W. M., Hammond J. J., Thomas J. C., Overturf M. L., Zama A. Prazosin and clonidine for moderately severe hypertension. JAMA 1978; 240: 2553
   PubMed Web of Science ®Google Scholar
• Landahl S., Steen B. Läkemedelskonsumtion hos 70-äringar i Göteborg. Läkartidn 1975; 72: 5158
   PubMedGoogle Scholar
• Larsson-Cohn U., Wallentin L. Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. I. Glucose, insulin and human growth hormone levels during oral glucose tolerance tests. Acta Endocrinol (Kbh) 1977; 86: 583
   PubMedGoogle Scholar
• Lebech P. E., Borggaard B. Serum lipid and antithrombin-III changes effected by synthetic and natural estrogen therapy. The Menopausal Syndrome, R. B. Greenblatt, V. B. Mahesh, P. G. McDonough. Medcom Press. 1974
   Google Scholar
• Lewis P. J., Kohner E. M., Petrie A., Dollery C. T. Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment. Lancet 1976; i: 564
   Google Scholar
• Magnani H. N., Moore B. The effect of sequential mestranol-norethisterone on the circulating lipid levels of pre- and postmenopausal women, and its possible significance. Postgrad Med J Suppl 1976; 6: 55
   Google Scholar
• McNeilly A. S., Hagen C. Prolactin, TSH, LH and FSH responses to a combined LHRH-TRH test at different stages of the menstrual cycle. Clin Endocrinol 1974; 3: 427
   PubMedGoogle Scholar
• Nachtigall L. E., Nachtigall R. H., Nachtigall R. D., Beckman E. M. Estrogen replacement therapy. II. A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1979; 54: 74
   PubMed Web of Science ®Google Scholar
• Notelovitz M. Metabolic effect of conjugated oestrogens (USP) on glucose tolerance. S Afr Med J 1974; 48: 2599
   Google Scholar
• Notelovitz M. Effect of natural oestrogens on blood pressure and weight in postmenopausal women. S Afr Med J 1975; 49: 2251
   PubMed Web of Science ®Google Scholar
• Notelovitz M. The effect of long-term oestrogen replacement therapy on glucose and lipid metabolism in postmenopausal women. S Afr Med J 1976; 50: 2001
   Google Scholar
• Pfeffer R. I., Van den Noort S. Estrogen use and stroke risk in postmenopausal women. Am J Epidemiol 1976; 103: 445
   PubMed Web of Science ®Google Scholar
• Pyörälä T. The effect of synthetic and natural estrogens on glucose tolerance, plasma insulin and lipid metabolism in post-menopausal women. The Management of the Menopause and Postmenopausal Years, S. Campbell. MTP Press, Lancaster, England 1976; 195
   Google Scholar
• Robinson R. W., Lebeau R. J. Effect of conjugated equine estrogens on serum lipids and the clotting mechanism. J Atheroscl Res 1965; 5: 120
   Google Scholar
• Smith W. M. Diuretics and cholesterol elevation. JAMA 1979; 242: 1612
   Google Scholar
• Stern M. P., Brown B. W., Jr., Haskell W. L., Farquhar J. W., Wehrle C. L., Wood F. D. S. Cardiovascular risk and use of estrogens or estrogenprogestagen combinations. Stanford three-community study. JAMA 1976; 235: 811
   PubMed Web of Science ®Google Scholar
• Thom M. H., White P. J., Williams R. W., Sturdee D. W., Paterson M. E. L., Wade-Evans T., Studd J. W. W. Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. Lancet 1979; ii: 455
   Google Scholar
• Tikkanen M. J., Nikkala E. A., Vartiainen E. Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women. Lancet 1978; ii: 490
   Google Scholar
• Wallace R. B., Hoover J., Barrett-Connor E., Rifkin B. M., Hunninghake D. B., Mackenthun A., Heiss G. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Report from the medications working group of the lipid research clinics program. Lancet 1979; ii: 111
   Google Scholar
• Wallentin L., Larsson-Cohn U. Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids. Acta Endocrinol (Kbh) 1977; 86: 597
   PubMedGoogle Scholar
• Wallentin L., Larsson-Cohn U. Postmenopausal oestrogen replacement and lipids. Lancet 1977; i: 1358
   Google Scholar
• Weiss N. S., Szekely D. R., English D. R., Schweid A. I. Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA 1979; 242: 261
   PubMed Web of Science ®Google Scholar
• Yendt E. R., Cohanim M. Prevention of calcium stones with thiazides. Kidney Int 1978; 13: 397
   PubMed Web of Science ®Google Scholar